Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00364104 · ClinicalTrials.gov registry record · Phase 3
Helicobacter Pylori Eradication Trial to Reduce Iron Deficiency in Children
A Phase 3 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 3
- Development phase
- 125
- Enrollment target
NCT00364104: Completed Phase 3 study, sponsored by The University of Texas Health Science Center, Houston.
NCT00364104 is a Phase 3 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 125 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00364104, a Phase 3 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 125 participants
- Enrollment target
Study Summary
The investigators hypothesize that the Helicobacter pylori bacterium decreases iron from the stomach and that this effect of the infection can be identified among persons with iron deficiency as well as among persons with normal iron stores. The aim of this study is to determine whether Helicobacter pylori eradication in children is followed by an increase in markers of iron stores after six to twelve months of treatment.
Interventions
- DRUG Placebo
- DRUG Ferrous sulfate
- DRUG Quadruple sequential Helicobacter pylori eradication + iron sulfate
- DRUG Quadruple sequential Helicobacter pylori eradication therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2007-03 |
| Est. Completion | 2008-12 |
| Phase | Phase 3 |
What the finished NCT00364104 record still lists
NCT00364104 is an interventional study that assigns participants to a tested intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (84% lower).
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT00364104 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00364104 about?
NCT00364104 is a clinical study titled "Helicobacter Pylori Eradication Trial to Reduce Iron Deficiency in Children". The investigators hypothesize that the Helicobacter pylori bacterium decreases iron from the stomach and that this effect of the infection can be identified among persons with iron deficiency as well as among persons with normal iron stores. The aim of this study is to determine whether Helicobacter...
What is the current status of trial NCT00364104?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 125 participants. The study started on 2007-03. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00364104?
The interventions under investigation include: Placebo (DRUG), Ferrous sulfate (DRUG), Quadruple sequential Helicobacter pylori eradication + iron sulfate (DRUG), Quadruple sequential Helicobacter pylori eradication therapy (DRUG).
Who is sponsoring clinical trial NCT00364104?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00364104's enrollment target sits among peer trials
125 1605th of 2000 higher than 391 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02717039 · 125 participants
Pharmacogenomics of Heparin-Induced Thrombocytopenia
- NCT02763033 · 125 participants · Phase 2
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
- NCT02793999 · 125 participants
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- NCT03003299 · 125 participants · NA
PARTNER 3 Trial - Aortic Valve-in-Valve
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia